4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001415889-18-001226
Options or other derivatives
- VP CORPORATE DEVELOPMENT acquired 150,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| MCPARTLAND MARK A. VP CORPORATE DEVELOPMENT | 2018-08-05 | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | D | ||
Loading xslF345X03/form4-08062018_010833.xml…